Support Alert

Class 4 medicines defect information: Kyowa Kirin Bleo-Kyowa Powder for Solution for Injection 15,000 IU

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a class 4 drug alert (caution in use) for a specified batch of Bleo-Kyowa, Powder for Solution for Injection, 15,000 IU (Bleomycin sulfate).

Some of our content, including support alerts, is only available to RPS members. 

Log in

Find out more about membership of the Society

Return To Top